IL155231A0 - New nmr screening method - Google Patents

New nmr screening method

Info

Publication number
IL155231A0
IL155231A0 IL15523101A IL15523101A IL155231A0 IL 155231 A0 IL155231 A0 IL 155231A0 IL 15523101 A IL15523101 A IL 15523101A IL 15523101 A IL15523101 A IL 15523101A IL 155231 A0 IL155231 A0 IL 155231A0
Authority
IL
Israel
Prior art keywords
screening method
nmr screening
new nmr
new
screening
Prior art date
Application number
IL15523101A
Original Assignee
Biovitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovitrum Ab filed Critical Biovitrum Ab
Publication of IL155231A0 publication Critical patent/IL155231A0/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01RMEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00Arrangements or instruments for measuring magnetic variables
    • G01R33/20Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/46NMR spectroscopy
    • G01R33/465NMR spectroscopy applied to biological material, e.g. in vitro testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
IL15523101A 2000-10-20 2001-10-19 New nmr screening method IL155231A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0003811A SE0003811D0 (en) 2000-10-20 2000-10-20 Screening methods
PCT/SE2001/002281 WO2002033406A1 (en) 2000-10-20 2001-10-19 New nmr screening method

Publications (1)

Publication Number Publication Date
IL155231A0 true IL155231A0 (en) 2003-11-23

Family

ID=20281503

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15523101A IL155231A0 (en) 2000-10-20 2001-10-19 New nmr screening method

Country Status (7)

Country Link
EP (1) EP1327144A1 (en)
JP (1) JP2004523732A (en)
AU (1) AU2001296165A1 (en)
CA (1) CA2424562A1 (en)
IL (1) IL155231A0 (en)
SE (1) SE0003811D0 (en)
WO (1) WO2002033406A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20025738D0 (en) 2002-11-29 2002-11-29 Amersham Health As Method
WO2005073747A1 (en) * 2004-02-02 2005-08-11 Mitsubishi Chemical Corporation Nmr signal assignment method
JP2007255910A (en) * 2006-03-20 2007-10-04 Hokkaido Univ Assigning method of nmr signal

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698401A (en) * 1995-11-14 1997-12-16 Abbott Laboratories Use of nuclear magnetic resonance to identify ligands to target biomolecules

Also Published As

Publication number Publication date
EP1327144A1 (en) 2003-07-16
SE0003811D0 (en) 2000-10-20
JP2004523732A (en) 2004-08-05
AU2001296165A1 (en) 2002-04-29
CA2424562A1 (en) 2002-04-25
WO2002033406A1 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
EP1378749A4 (en) Screening method
EP1469316A2 (en) Screening method
GB0009358D0 (en) Compound screening method
GB9922352D0 (en) Screening method
IL147637A0 (en) Sequence based screening
GB0111004D0 (en) Screening method
GB9923075D0 (en) Screening method
EP1237001A4 (en) Screening method
GB0012992D0 (en) Test method
GB0009363D0 (en) Compound screening method
IL155231A0 (en) New nmr screening method
GB9820988D0 (en) Screening method
GB0111712D0 (en) Compound screening method
GB9902696D0 (en) Screening methods
GB0021682D0 (en) Screening method 2
GB0019721D0 (en) Novel method
GB9928789D0 (en) Naive screening method
GB0009503D0 (en) Screening method for compounds
GB0029373D0 (en) Screening method
GB0004629D0 (en) Screening method
GB0031273D0 (en) Screening method
GB0030504D0 (en) Screening method
SI1305636T1 (en) Screening method
GB0021434D0 (en) Novel method
AU2000224577A1 (en) Screening method